February 2013

Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation

Conditions:   Primary Simultaneous Kidney and Pancreas Allograft Candidates;   Simultaneous Kidney and Pancreas Transplantation
Interventions:   Biological: Belatacept;   Drug: methylprednisolone;   Biological: Anti-thymocyte Globulin (Rabbit);   Drug: Tacrolimus;   Drug: Mycophenolate mofetil
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Clinical Trials in Organ Transplantation
Terminated - verified December 2016